Publication | Closed Access

Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status

MedicinePathologyK-ras Mutation StatusFront-line ChemotherapyBronchial NeoplasmCancer TreatmentClinical OutcomeOncologyRadiation OncologyLung Cancer